Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Spergel

Showing results (491-500 of 590) with videos related to

Pageof 59
Sort By:
The Journal of Allergy and Clinical Immunology|August 8, 2009
17q12-21 variants interact with smoke exposure as a risk factor for pediatric asthma but are equally associated with early-onset versus late-onset asthma in North Americans of European ancestryJames H Flory, Patrick M Sleiman, Jason D Christie, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 16, 2023
Accelerating Food Allergy Research: Need for a Data CommonsRuchi S Gupta, Shruti Sehgal, Mark Wlodarski, et al.
Journal of Medicinal Chemistry|December 19, 1998
Biphenylsulfonamide endothelin antagonists: structure-activity relationships of a series of mono- and disubstituted analogues and pharmacology of the orally active endothelin antagonist 2'-amino-N- (3,4-dimethyl-5-isoxazolyl)-4'-(2-methylpropyl)[1, 1'-biphenyl]-2-sulfonamide (BMS-187308)N Murugesan, Z Gu, P D Stein, et al.
The New England Journal of Medicine|June 26, 2024
Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 Years of AgeMirna Chehade, Evan S Dellon, Jonathan M Spergel, et al.
The American Journal of Gastroenterology|April 23, 2019
Increasing Rates of Diagnosis, Substantial Co-Occurrence, and Variable Treatment Patterns of Eosinophilic Gastritis, Gastroenteritis, and Colitis Based on 10-Year Data Across a Multicenter ConsortiumRobert D Pesek, Craig C Reed, Amanda B Muir, et al.
The Journal of Allergy and Clinical Immunology|June 10, 2021
Polygenic prediction of atopic dermatitis improves with atopic training and filaggrin factorsChristopher H Arehart, Michelle Daya, Monica Campbell, et al.
The Journal of Allergy and Clinical Immunology|September 10, 2016
Omalizumab facilitates rapid oral desensitization for peanut allergyAndrew J MacGinnitie, Rima Rachid, Hana Gragg, et al.
The Journal of Allergy and Clinical Immunology|June 14, 2023
Rapid reduction in Staphylococcus aureus in atopic dermatitis subjects following dupilumab treatmentEric L Simpson, Patrick M Schlievert, Takeshi Yoshida, et al.
The World Allergy Organization Journal|January 9, 2018
The global impact of the DRACMA guidelines cow's milk allergy clinical practiceAlessandro Fiocchi, Holger Schunemann, Ignacio Ansotegui, et al.
The Journal of Allergy and Clinical Immunology|April 24, 2026
Dupilumab normalizes the eosinophilic esophagitis disease transcriptomeWei Keat Lim, Matthew F Wipperman, Marc E Rothenberg, et al.
Pageof 59

Showing results (491-500 of 590) with videos related to

Sort By:
Pageof 59
The Journal of Allergy and Clinical Immunology|August 8, 2009
17q12-21 variants interact with smoke exposure as a risk factor for pediatric asthma but are equally associated with early-onset versus late-onset asthma in North Americans of European ancestryJames H Flory, Patrick M Sleiman, Jason D Christie, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 16, 2023
Accelerating Food Allergy Research: Need for a Data CommonsRuchi S Gupta, Shruti Sehgal, Mark Wlodarski, et al.
Journal of Medicinal Chemistry|December 19, 1998
Biphenylsulfonamide endothelin antagonists: structure-activity relationships of a series of mono- and disubstituted analogues and pharmacology of the orally active endothelin antagonist 2'-amino-N- (3,4-dimethyl-5-isoxazolyl)-4'-(2-methylpropyl)[1, 1'-biphenyl]-2-sulfonamide (BMS-187308)N Murugesan, Z Gu, P D Stein, et al.
The New England Journal of Medicine|June 26, 2024
Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 Years of AgeMirna Chehade, Evan S Dellon, Jonathan M Spergel, et al.
The American Journal of Gastroenterology|April 23, 2019
Increasing Rates of Diagnosis, Substantial Co-Occurrence, and Variable Treatment Patterns of Eosinophilic Gastritis, Gastroenteritis, and Colitis Based on 10-Year Data Across a Multicenter ConsortiumRobert D Pesek, Craig C Reed, Amanda B Muir, et al.
The Journal of Allergy and Clinical Immunology|June 10, 2021
Polygenic prediction of atopic dermatitis improves with atopic training and filaggrin factorsChristopher H Arehart, Michelle Daya, Monica Campbell, et al.
The Journal of Allergy and Clinical Immunology|September 10, 2016
Omalizumab facilitates rapid oral desensitization for peanut allergyAndrew J MacGinnitie, Rima Rachid, Hana Gragg, et al.
The Journal of Allergy and Clinical Immunology|June 14, 2023
Rapid reduction in Staphylococcus aureus in atopic dermatitis subjects following dupilumab treatmentEric L Simpson, Patrick M Schlievert, Takeshi Yoshida, et al.
The World Allergy Organization Journal|January 9, 2018
The global impact of the DRACMA guidelines cow's milk allergy clinical practiceAlessandro Fiocchi, Holger Schunemann, Ignacio Ansotegui, et al.
The Journal of Allergy and Clinical Immunology|April 24, 2026
Dupilumab normalizes the eosinophilic esophagitis disease transcriptomeWei Keat Lim, Matthew F Wipperman, Marc E Rothenberg, et al.
Pageof 59